Ondo Finance has reached a platform-wide total value locked (TVL) of over $4 billion, highlighting significant growth in its tokenized-asset business. Tokenized stocks and exchange-traded funds (ETFs) alone account for more than $1.3 billion of this value. The platform serves over 1 million holders and offers a range of tokenized assets including Treasurys, stocks, ETFs, portfolios, and private-market assets. Ondo Stocks facilitates liquidity by connecting to traditional financial exchanges through a request-for-quote trading system and supports permissionless transfers on Solana, Ethereum, and BNB Chain, positioning itself as a major player in digital asset tokenization.
Ondo Finance's platform TVL surpassing $4 billion provides context for digital asset interest. For readers following Pluang's cryptocurrency market, here is a snapshot as of Oct 14, 2026 21:02 WIB: out of 50 major cryptocurrencies, only 6 rose while 43 fell. Notable gainers include XNO (Nano) up 15.13% at Rp6.634 with a typical hold time of 86 days and 100% sell order activity, BAL (Balancer) up 11.14% at Rp16.297 with 85 days hold time, and EOS (EOS.IO) up 8.13% at Rp12.649 with 87 days hold time.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
